CS Mitsiades. CD44v6, a target for novel antibody treatment approaches, is frequently expressed in multiple myeloma and associated with deletion of chromosome arm 13q. haematol [Internet]. 2005Apr.1 [cited 2024Nov.23];90(4):436-7. Available from: https://haematologica.org/article/view/3504